Učitavanje...
Protective actions of administered mesenchymal stem cells in acute kidney injury: relevance to clinical trials
Current therapies for acute kidney injury remain primarily supportive and have failed to reduce morbidity, mortality (>50%), and associated costs. This prompted our studies in which rats with bilateral ischemia/reperfusion-induced acute kidney injury were treated with bone marrow-derived, culture...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group
2011
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4089688/ https://ncbi.nlm.nih.gov/pubmed/25018910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/kisup.2011.24 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|